Skip to content

Study of Management of Large Bone Defects.

An international, multicenter, prospective registry to investigate treatment options and their outcomes on post-traumatic long bones defects - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/066962
Enrollment
600
Registered
2024-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T07- Unspecified multiple injuries

Interventions

Intervention1: NIL: NIL

Sponsors

AO Innovation Translation Center (AO ITC)
Lead Sponsor
AO Innovation Translation Center AO ITC
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age = 18 years 2. Skeletally mature 3. Posttraumatic aseptic long bone defect > 2 cm in each cortex in humerus, femur or tibia, either 3a. initially after injury or 3b. after surgical debridement 4. Informed consent obtained, i.e.: 4a. Ability to understand the content of the patient information/ICF 4b. Willingness and ability to participate in the clinical investigation according to the registry plan 4c. Signed and dated EC/IRB approved written informed consent OR Written consent is provided according to the IRB/EC defined and approved procedures for patients who are not able to provide independent written informed consent

Exclusion criteria

Exclusion criteria: 1. Any oblique defect that has less than 8 cm expansion when adding the defect size of all four cortices 2. Any not medically managed severe systemic disease 3. Pregnancy 4. Prisoners 5. Participation in any other medical device or medicinal product registry within the previous 3 months that could influence the results of the present registry

Design outcomes

Primary

MeasureTime frame
Outcome of management of post -traumatic long bones defects, To evaluate outcome and the quality of life after the treatment.Timepoint: 3 years enrollment period

Secondary

MeasureTime frame
To describe patients characteristics and type of bone defect present, To evaluate the nature of the bone defect, induced by various causes, To describe surgical details and treatment modalities how the bone defect is treatedTimepoint: 36 months

Countries

Belgium, Germany, India, Switzerland, United Kingdom, United States of America

Contacts

Public ContactRohit Kumar

Paras HMRI Hospital Patna

jsbhadani@gmail.com06127107921

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026